The Law Offices of Frank R. Cruz Announces Investigation of Cytokinetics, Incorporated (CYTK) on Behalf of Investors

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Cytokinetics, Incorporated regarding possible breaches of fiduciary duties to shareholders [1] Group 1 - Cytokinetics disclosed that the FDA has extended the review period for its cardiac myosin inhibitor drug, aficamten, by three months [1]